← Back to Patent Explorer
US4191176A Expired / Lapsed US ⏱️ 0.0 years remaining

Intralenticular cataract surgery

Assignee: Novo Laboratories Inc
•
Filing: 1977-08-23
•
Granted: 1980-03-04
•
Expires: 1997-08-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An enzymatic intralenticular cataract treatment for removal of nuclear cortical and subcapsular regions of the cataractous lens through enzymatic digestion thereof which comprises introduction of a concentrated solution of a trypsin enzyme into the nuclear and cortical regions of a cataractous lens, and after enzymatic digestion removing the liquefied cataractous material. The procedure allows subsequent removal of the nuclear, cortical and subcapsular portions of a cataractous lens through a very tiny incision in the eye and lens capsule, leaving all other structures within the eye intact. Bovine and porcine trypsins are preferred.

Inventors

  • 👤 Joseph Spina
  • 👤 Michael K. Weibel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:28
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/007; A61F9/00736; A61M; A61M2210/00; A61M2210/06; A61M2210/0612

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 42 words
A method for enzymatically treating cataracts in vivo which comprises injecting a concentrated solution of a trypsin directly into the lens of an eye, then allowing enzymatic digestion of the lens to take place and thereafter removing the enzyme digested lens material.
Claim 2
Independent Claim 42 words
A method for enzymatically treating cataracts in vivo which comprises injecting a concentrated solution of a trypsin directly into the lens of an eye, then allowing enzymatic digestion of the lens to take place and thereafter removing the enzyme digested lens material.
Claim 3
Dependent Claim 15 words
The method of claim 1 wherein a tracking indicator is included in the enzyme solution.
Claim 4
Dependent Claim 11 words
The method of claim 1 wherein the trypsin is bovine trypsin.
Claim 5
Dependent Claim 11 words
The method of claim 1 wherein the trypsin is porcine trypsin.
Claim 6
Dependent Claim 13 words
The method of claim 1 wherein said removal is by irrigation and aspiration.
Claim 7
Dependent Claim 12 words
The method of claim 1 wherein the trypsin concentration is 0.1-10 mg/ml.
Claim 8
Dependent Claim 23 words
The method of claim 1 wherein the trypsin concentration is 0.1-10 mg/ml and wherein 0.01-1.0% w/v of fluorescein is present in the solution.

References Cited (Backward Citations)

US3320131A Cited
US3589363A Cited
US3683069A Cited
US4078564A Cited
US4078564B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-03-04 1983-09-03 1984-03-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-03-04 1987-09-03 1988-03-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-03-04 1991-09-03 1992-03-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag